Indirubin, a bisindole alkaloid from Isatis indigotica , reduces H1N1 susceptibility in stressed mice by regulating MAVS signaling

• Published in: Oncotarget Vol. 8; no. 62; pp. 105615 - 105629
• Main Authors: Jie, Chong, Luo, Zhuo, Chen, Huan, Wang, Min, Yan, Chang, Mao, Zhong-Fu, Xiao, Gao-Keng, Kurihara, Hiroshi, Li, Yi-Fang, He, Rong-Rong
• Format: Journal Article
• Language: English
• Published: United States Impact Journals LLC 01.12.2017
• Subjects: Research Paper; influenza virus; indirubin; STING; MAVS; virus susceptibility
• ISSN: 1949-2553; 1949-2553
• DOI: 10.18632/oncotarget.22350

has a long history in treating virus infection and related symptoms in China. Nevertheless, its antivirus evidence in animal studies is not satisfactory, which might be due to the lack of appropriate animal model. Previously, we had utilized restraint stress to establish mouse H1N1 susceptibility model which was helpful in evaluating the anti-virus effect of medicines targeting host factors, such as type I interferon production. In this study, this model was employed to investigate the effect and mechanism of indirubin, a natural bisindole alkaloid from , on influenza A virus susceptibility. In the study, the stress hormone corticosterone was used to simulate restraint stress. Our results demonstrated that indirubin decreased the susceptibility to influenza virus with lowered mortality and alleviated lung damage in restraint-stressed mice model. Moreover, indirubin promoted the expression of interferon-β and interferon inducible transmembrane 3. In addition, indirubin maintained the morphology and function of mitochondria following influenza A virus infection. Further study revealed that indirubin promoted interferon-β production through promoting mitochondrial antiviral signaling pathway. Our study indicated that indirubin could be a candidate for the therapy of influenza.